Article
Colibactin DNA-damage signature indicates mutational impact in colorectal cancer.
Nature medicine - 1 Jul 2020
Dziubańska-Kusibab Paulina J, Berger Hilmar, Battistini Federica, Bouwman Britta A M, Iftekhar Amina, Katainen Riku, Cajuso Tatiana, Crosetto Nicola, Orozco Modesto, Aaltonen Lauri A, Meyer Thomas F
Abstract excerpt
The mucosal epithelium is a common target of damage by chronic bacterial infections and the accompanying toxins, and most cancers originate from this tissue. We investigated whether colibactin, a potent genotoxin1 associated with certain strains of Escherichia coli2, creates a specific DNA-damage signature in infected human colorectal cells. Notably, the genomic contexts of colibactin-induced DNA double-strand...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
